871589-86-5

Basic information

• Product Name: (3R,5R)-5-(((1R),(2R),(3S))-3-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)cyclopentan-1-yl)-3-benzyloxycarboxylamino-3-methylpyrrolidin-2-one
• Synonyms: (3R,5R)-5-(((1R),(2R),(3S))-3-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)cyclopentan-1-yl)-3-benzyloxycarboxylamino-3-methylpyrrolidin-2-one
• CAS NO: 871589-86-5
• Molecular Weight: 666.636
• Mol File: 871589-86-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (3R,5R)-5-(((1R),(2R),(3S))-3-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)cyclopentan-1-yl)-3-benzyloxycarboxylamino-3-methylpyrrolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,5R)-5-(((1R),(2R),(3S))-3-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)cyclopentan-1-yl)-3-benzyloxycarboxylamino-3-methylpyrrolidin-2-one(871589-86-5)
• EPA Substance Registry System: (3R,5R)-5-(((1R),(2R),(3S))-3-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)cyclopentan-1-yl)-3-benzyloxycarboxylamino-3-methylpyrrolidin-2-one(871589-86-5)

Safety Data

• Hazardous Substances Data: 871589-86-5(Hazardous Substances Data)

Upstream product

• 171860-41-6 (S,S)-4-methyl-5-oxo-2-phenyl-oxazolidine-3-carboxylic acid benzyl ester 
• 34250-16-3 3-oxocyclopent-1-ene-1-carbonitrile 
• 368-63-8 (R)-[3,5-bis(trifluoromethyl)phenyl]ethanol 
• 10481-34-2 2-bromo-2-cyclopenten-1-one 
• 930-30-3 cyclopent-2-enone 
• 1007593-16-9 C₄₁H₃₆F₇NO₆ 
• 1007593-46-5 C₂₃H₂₀F₇IO₂ 
• 1007592-25-7 C₂₃H₂₁F₇O₂ 
• 1007591-49-2 C₂₃H₂₁F₇O₂ 
• 1007592-12-2 C₁₇H₁₆F₆O₂ 
• 1007591-98-1 C₁₆H₁₃F₆NO 
• 1007591-93-6 C₁₇H₁₃NO₂ 
• 1007591-88-9 (S)-3-hydroxycyclopent-1-enecarbonitrile 
• 871589-85-4 (3R,5R)-5-(((1R),(2R),(3S))-3-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)cyclopentan-1-yl)-3-carboxy-3-methylpyrrolidin-2-one 

Relevant articles and documents

Enantioselective, biocatalytic reduction of 3-substituted cyclopentenones: Application to the asymmetric synthesis of an hNK-1 receptor antagonist

A convergent and enantioselective route to the hNK-1 receptor antagonist (1) is described, which sets all six stereogenic centers with high diastereoselectivity and delivers 1 in only 11 steps and 23% overall yield. The process was enabled by the developm

PROCESS FOR MAKING LACTAM TACHYKININ RECEPTOR ANTAGONISTS

The present invention is directed to a process for preparing certain α,α disubstituted γ-lactam derivatives that are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The compounds are useful i

Lactam tachykinin receptor antagonists

The present invention is directed to certain lactam compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations compri